Mikael Dolsten Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mikael Dolsten.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mikael Dolsten. Mikael Dolsten is a Sr. VP & Pres., Wyeth Research in WYETH ($WYE) and a President R&D in PFIZER INC ($PFE) and a Director in Karyopharm Therapeutics Inc. ($KPTI).
Address: 5 GIRALDA FARMS MADISON 07940 NJ
Companies in which Mikael Dolsten is an Insider
Karyopharm Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mikael Dolsten: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 21 2021
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PFIZER INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mikael Dolsten: President R&D
Holdings: 156,568 shares
Current Value: $5,022,701
Latest Transaction: Mar 01 2021
$PFE Market Capitalization: $195.04B
$PFE Previous Close: $32.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WYETH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mikael Dolsten: Sr. VP & Pres., Wyeth Research
Holdings: 0 shares
Latest Transaction: Oct 19 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mikael Dolsten
Sentiment: All, KPTI, PFE, WYE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21 2021 | KPTI | Karyopharm Therape ... | Dolsten Mikael | Director | Option Exercise | A | 9.42 | 23,900 | 225,138 | 23,900 | |
| Mar 01 2021 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Option Exercise | A | 33.82 | 182,050 | 6,156,931 | 182,050 | |
| Mar 01 2021 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Option Exercise | A | 33.82 | 210,697 | 7,125,773 | 210,697 | |
| Mar 01 2021 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Payment of Exercise | F | 33.82 | 28,271 | 956,125 | 156,568 | 184.8 K to 156.6 K (-15.29 %) |
| May 19 2020 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Sell | S | 37.79 | 24,242 | 916,105 | 174,918 | 199.2 K to 174.9 K (-12.17 %) |
| May 19 2020 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Sell | S | 37.78 | 17,357 | 655,747 | 199,160 | 216.5 K to 199.2 K (-8.02 %) |
| May 19 2020 | PFE | PFIZER INC | Dolsten Mikael | President R&D | Sell | S | 37.80 | 16,840 | 636,552 | 216,517 | 233.4 K to 216.5 K (-7.22 %) |